Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.6.3 appeared in the record history, indicating a site/system update to the page. It does not reflect changes to the study data or eligibility details.SummaryDifference0.1%

- Check19 days agoChange DetectedRecord history shows a new revision tag: Revision: v3.6.2, replacing the earlier Revision: v3.6.0. This appears to be an administrative update to the study record metadata rather than a change to study data or content.SummaryDifference0.1%

- Check33 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants, signaling enrollment has completed. A new record revision (v3.6.0) was added and a previous revision (v3.5.5) was removed, reflecting versioning in the study history.SummaryDifference0.4%

- Check40 days agoChange DetectedNew history entry v3.5.5 was added to the page. The previous entry v3.5.4 was removed, reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe Record History now shows a new revision entry labeled v3.5.4, replacing the previous v3.5.3. This reflects an update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdated the website interface revision label from v3.5.2 to v3.5.3 on the record history page.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.